Literature DB >> 2583241

Association of [3H]zacopride with 5-HT3 binding sites.

L M Pinkus1, N S Sarbin, D S Barefoot, J C Gordon.   

Abstract

An assay was developed for [3H]zacopride binding to 5-HT3 specific sites in membranes from rabbit ileum muscularis. The binding was rapid, saturable, reversible, salt-insensitive, unaffected by pH between 6.5 and 9.5, and of high affinity (apparent KD = 0.65 +/- 0.15 nM). ICS 205-930, a potent 5-HT3 antagonist that inhibited competitively, was utilized to define 5-HT3 specific binding. Other 5-HT3 antagonists and agonists, although exhibiting marked differences in potency, were also effective inhibitors; whereas, antagonists of other classes of serotonin receptors, guanyl nucleotides and numerous receptor-specific ligands, including peptide hormones, were inactive. Vagus nerve exhibited the greatest amount of 5-HT3 specific binding amongst rabbit tissues and virtually all of the [3H]zacopride was bound to 5-HT3 binding sites. In rabbit, rat and ferret a fairly uniform distribution of 5-HT3 binding sites was observed along the muscularis of the small bowel. [3H]Zacopride is a high-affinity ligand for detecting 5-HT3 binding sites and rabbit small bowel muscularis membranes are a sensitive system for evaluating the potency of 5-HT3 antagonists or agonists.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583241     DOI: 10.1016/0014-2999(89)90797-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Neuropharmacology of emesis in relation to clinical response.

Authors:  B Costall; R J Naylor
Journal:  Br J Cancer Suppl       Date:  1992-12

2.  Identification and distribution of 5-HT3 recognition sites in the rat gastrointestinal tract.

Authors:  S Champaneria; B Costall; R J Naylor; D W Robertson
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

3.  Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.

Authors:  R M Eglen; S R Swank; L K Walsh; R L Whiting
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

4.  Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stem.

Authors:  J M Barnes; N M Barnes; B Costall; I L Naylor; R J Naylor; J A Rudd
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

5.  Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.

Authors:  J M Barnes; N M Barnes; B Costall; S M Jagger; R J Naylor; D W Robertson; S Y Roe
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

6.  Characterization of the binding of [3H]-clobenpropit to histamine H3-receptors in guinea-pig cerebral cortex membranes.

Authors:  E A Harper; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

7.  5-hydroxytryptamine strongly inhibits fluid secretion in guinea pig pancreatic duct cells.

Authors:  A Suzuki; S Naruse; M Kitagawa; H Ishiguro; T Yoshikawa; S B Ko; A Yamamoto; H Hamada; T Hayakawa
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 8.  The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.

Authors:  D C Ohuoha; T M Hyde; J E Kleinman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.

Authors:  E H Wong; R Clark; E Leung; D Loury; D W Bonhaus; L Jakeman; H Parnes; R L Whiting; R M Eglen
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

10.  Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.

Authors:  G A Higgins; P Nguyen; N Joharchi; E M Sellers
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.